Accelerated partial breast irradiation: The case for current use

Breast Cancer Research

Volumn 7, Issue 3, 2005, Pages 106-109

  Keisch, Martin E ^a  

^a Mount Sinai Comprehensive Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BALLOON CATHETER; BEAM THERAPY; BRACHYTHERAPY; BREAST CANCER; CANCER CONTROL; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DOSE CALCULATION; EUROPE; HUMAN; IMPLANT; INTRAOPERATIVE PERIOD; PARTIAL MASTECTOMY; PATIENT SELECTION; POSTOPERATIVE PERIOD; PROCESS OPTIMIZATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

BREAST NEOPLASMS; CLINICAL TRIALS; DOSE FRACTIONATION; FEMALE; HUMANS; INFORMED CONSENT; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; PATIENT SELECTION; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT;

EID: 18944370365     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr992     Document Type: Article

References (31)

1. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of randomized trial. Ann Oncol 2001, 12:997-1003.
2. Vicini FA, Kestin L, Chen P, Benitez P, Goldstein NS, Martinez A: Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 2003, 95:1205-1211.
3. Cuttino LW, Arthur DW, Todor DA, et al.: CT- guided multi-catheter insertion technique for partial breast brachytherapy (PBB): Reliable target coverage and dose homogeneity. Brachytherapy 2003, 2:41-68.
4. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L: Compliance with consensus recommendation for the treatment of early stage breast carcinoma elderly women. Cancer 1999, 85:1104-1113.
5. Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR: Travel distance to radiation therapy and receipt of radiotherapy following breast conserving surgery. J Natl Cancer Inst 2000, 92:269-271.
6. Nattinger AB, Hoffmann RG, Kneusel RT, Schapira MM: Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast conserving surgery. Lancet 2000, 356:1148-1153.
7. Baxter NN, Virnig BA, Durham SB, Tuttle TM: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004, 96:443-448.
8. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, Edmundson G, Goldstein NS, Benitez P, Huang RR, et al.: Accelerated treatment of breast cancer. J Clin Oncol 2001, 19: 1993-2001.
9. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, Arthur D, Scroggins T, Streeter O: Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early stage breast cancer treated with breast conserving therapy. Int J Radiat Oncol Biol Phys 2003, 55:289-293.
10. Baglan KL, Sharpe MB, Jaffray D, Frazier RC, Fayad J, Kestin LL, Remouchamps V, Martinez AA, Wong J, Vicini FA: Accelerated partial breast irradiation using 3D conformal radiation therapy (3D-CRT). Int J Radiat Oncol Biol Phys 2003, 55:302-311.
11. Vaidya JS, Baum M, Tobias JS, D'Souza DP, Naidu SV, Morgan S, Metaxas M, Harte KJ, Sliski AP, Thomson E: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 2001, 12:1075-1080.
12. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, Ivaldi G, Tosi G, Ciocca M, Tosoni A, et al.: A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 2001, 37: 2178-2183.
13. Holland R, Veling SHJ, Mravunac M, Hendriks JH: Histologic multifocality of Tis, T1-2 breast carcinomas: Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56:979-990.
14. Imamura H, Haga S, Shimizu T, Watanabe O, Kinoshita J, Nagumo H, Kajiwara T, Aiba M: Relationship between morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat 2000, 62:177-184.
15. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, Wakasa H: Intraductal extension of primary invasive breast carcinoma treated by breast-conservative surgery. Cancer 1995, 76:32-45.
16. Goldstein NS, Kestin L, Vicini FV: Factors associated with ipsilateral breast failure and distant metastasis in patients with invasive breast carcinoma treated with breast conservation therapy. Am J Clin Pathol 2003, 120:485-488.
17. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, et al.: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 1992, 84:683-689.
18. Uppsala-Oreboro Breast Cancer Study Group: Sector resection with or without postoperative radiotherapy stage I breast cancer: a randomized trial. J Natl Cancer Inst 1990, 82:277-282.
19. Fisher B, Anderson S: Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. World J Surg 1994, 18:63-69.
20. Holli K, Saaristo R, Isola J, Joensuu H, Hakama M: Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: Results of a randomized study. Br J Cancer 2001, 84:164-169.
21. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
22. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, Mangel LC, Somogyi A, Kasler M, Nemeth G: Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 2002, 80: 121-128.
23. Kuske RR, Bolton JS: A Phase I/II Trail to Evaluate Brachytherapy as the Sole Method of Radiation Therapy for Stage I and II Breast Carcinoma. Radiation Therapy Oncology Group Publication no. 1055. Philadelphia, PA: Radiation Therapy Oncology Group; 1995.
24. Storme G, Van de Steene J, Vinh-Hung V, for the Open Meta-Analysis Project; Oncologisch Centrum, AZ-VUB, Brussels, Belgium: Radiation after lumpectomy for breast cancer improves survival: Lack of evidence was not lack of an effect [abstract 332]. Proc Am Soc Clin Oncol 2003, 22:83.
25. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS: The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 1993, 5: 278-283.
26. Fentiman IS, Deshame V, Tong D, Winter J, Mayles H, Chaudary MA: Caesium (137) implant as sole radiation therapy for operable breast cancer: a phase II trial. Radiother Oncol 2004, 71: 281-285.
27. Arthur DW, Vicini FA, Kuske RR, Wazer DE, Nag S; American Brachytherapy Society: Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 2002, 1:184-190.
28. Perera F, Yu E, Engel J, Holliday R, Scott L, Chisela F, Venkatesan V: Patterns of breast reoccurrence in a pilot study of Brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow up. Int J Radiat Oncol Biol Phys 2003, 57: 1239-1246.
29. American Society of Breast Surgeons: Consensus Statement for Accelerated Partial Breast Irradiation from the American Society of Breast Surgeons [http://www.breastsurgeons.org/officialstmts/officialstmt3.shtml]
30. Arthur D: Accelerated partial breast irradiation: a change in treatment paradigm for early breast cancer. J Surg Oncol 2003, 84:185-191.
31. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis,1,2 breast cancer. Ann J Surg 2000, 180:299-304.